| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.6M | +37.0% |
| SG&A Expense | $11.7M | -22.4% |
| Operating Income | -$25.2M | -1.2% |
| Net Income | -$23.5M | +4.7% |
| EPS (Basic) | -$1.91 | +13.2% |
| EPS (Diluted) | -$1.91 | +13.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -20.5% |
| Short-term Investments | $42.8M | +24.1% |
| Current Assets | $46.9M | +19.0% |
| Total Assets | $48.6M | +16.7% |
| Current Liabilities | $1.4M | -10.4% |
| Total Liabilities | $2.4M | -17.0% |
| Stockholders' Equity | $46.2M | +19.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.9M | -20.7% |
| Capital Expenditures | $33K | -71.3% |
| Investing Cash Flow | -$7.9M | +77.2% |
| Financing Cash Flow | $25.8M | — |
| Free Cash Flow | -$18.9M | -20.1% |